Dr Andreas Nikolis to present at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV)
MONTREAL, Oct. 5, 2013 /CNW Telbec/ - On the heels of receiving its Medical Device License from Health Canada for the Klox Biophotonic System for the treatment of acne vulgaris,
(also known as the Lumigel Cleanse System), KLOX Technologies Inc.
("KLOX") announced today that it will be presenting on October 5th its facial rejuvenation technology at the 22nd Congress of the European Academy of Dermatology and Venereology (EADV)
in Istanbul, Turkey. Dr. Andreas Nikolis' presentation is entitled "Biophotonics in facial rejuvenation. A prospective randomized
22nd Congress of the European Academy of Dermatology and Venereology (EADV)
- October 5th, 2013, Istanbul (Turkey)
Biophotonics in facial rejuvenation. A prospective randomized
Presenter: Dr. Andreas Nikolis, Plastic, Reconstructive and Aesthetic
Surgeon, Associate Professor of Plastic Surgery, Division of Plastic
Surgery, University of Montreal.
Saturday, October 5th, - 8:09 AM / 8:18 AM (EEST), ICC Istanbul Congress Center Taşkışla,
Street Harbiye, (Üsküdar 3 room), Istanbul
KLOX representatives will be at kiosk 123 for the duration of the event.
KLOX Technologies corporate account: @KLOXTech
About KLOX Technologies: Leveraging light-based biophotonic technologies
KLOX is a privately-owned company focused on the development and
commercialization of a unique, non-invasive biophotonic technology
using a primary device consisting of a multiple LED lighting system
that interacts with an oxygen-rich gel containing light-trapping
molecules. KLOX's cosmetics and medical devices are destined for the
rapidly growing aesthetics, dermatological, tissue repair and dental
SOURCE: KLOX Technologies Inc.
For further information:
NATIONAL Public Relations
+1 (514) 843-2345